Sanofi KSA launches next generation basal insulin

Dr. Abdul Rahman Al-Sheikh
Updated 06 March 2018
0

Sanofi KSA launches next generation basal insulin

The control of blood sugar levels in patients with diabetes stays sub-optimal, with one in two patients on treatment for diabetes not reaching their glycemic objectives. With the aim of resolving this unmet need of patients, Sanofi KSA has launched a next generation basal insulin.
Dr. Saud Al-Sifiri, head of the endocrinology department at Al-Hada Hospital, said: “The International Diabetes Federation Report 2015 showed that the prevalence of diabetes in Saudi Arabia is 20 percent in the adult population. This ranks Saudi Arabia as the highest in the Middle Eastern countries and No.6 worldwide. This is primarily due to increasing obesity, sedentary lifestyles and an aging population and is the cause of substantial morbidity and mortality.”
Dr. Abdul Rahman Al-Sheikh, professor of internal medicine and endocrinology at King Abdul Aziz University and chairman of the Saudi Diabetes Society, added: “Hypoglycemia is associated with a high cost for the patient, the health care system, and society at large; there has been associated direct cost of hypoglycemia like hospitalization, physician cost and emergency cost, and indirect cost including the absence from work, reduced work capability and other related accidents. All of these have a direct effect on reducing quality of life, and reduced or even lost work capacity are additional costs to society.”
Dr. Ahmed Serag said: “Sanofi is proud of its leadership and long heritage in diabetes and insulin therapies, consisting of a vast offering of insulins which have supported patients in the management of their diabetes for more than a year.
We are committed to bringing innovative therapies that go beyond the pill and intend to provide much better health results for individuals with diabetes in Saudi Arabia. With the introduction of the next generation basal insulin we provide a reliable option that will resolve some of the previously unmet needs of diabetic patients in the Kingdom.”
According to the WHO, it is estimated that there have been more than 760,000 emergency hospitalizations per year; due to diabetes.
The cost of diabetes is around SR17 billion ($4.53 billion) per year; it is estimated to rise to SR27 billion if undiagnosed patients undergo treatment and eventually it will rise even further to SR43 billion if pre-diabetic patients became diabetic.


LuLu Hypermarkets join in the National Day party

Updated 25 September 2018
0

LuLu Hypermarkets join in the National Day party

A wide variety of social and cultural programs were arranged at all the LuLu Hypermarkets outlets across the Kingdom as part of the 88th National Day celebrations.
The grand inauguration of the National Day celebrations was held on Sunday at 9 p.m. at LuLu’s newly opened outlet in Atyaf Mall, Yarmouk. A massive 88-meter-long cake was cut, representing 88 years in the history of the Kingdom, in the esteemed presence of Faisal H. Al-Jarba, vice chairman of Nameyah International.
LuLu extended its National Day wishes to all Saudi Arabian citizens and also conveyed its gratitude to the rulers and people of the Kingdom for helping to make LuLu the largest hypermarket group in Saudi Arabia.
“We are pleased to offer a diverse collection of Saudi products at attractive prices. Because of our customer-friendly services throughout a decade, LuLu has become the ultimate spot for a memorable shopping experience with friends and family,” said Bashar Naser Al-Bashar, head of administration at LuLu Saudi Hypermarkets.
“This year our celebrations are the first of their kind and we are so much pleased to offer a diverse collection of locally grown fruits, vegetables, and other Saudi products at attractive prices," said Al-Bashar.